Noteworthy, in a recent study on the upper airway host transcriptional response of patients with COVID-19 to other viral lung infections SYNGR2 was found to be upregulated >1.035-fold and 1.35-fold when compared with nonviral respiratory disorders (Mick et al., 2020). This evidence concerns the gene SYNGR2 and COVID-19.